Literature DB >> 30660461

5 Years of Serial Intravascular Imaging Outcomes of XINSORB Sirolimus-Eluting Bioresorbable Vascular Scaffold.

Yizhe Wu1, Li Shen1, Jiasheng Yin1, Jiahui Chen1, Lei Ge2, Junbo Ge3.   

Abstract

Entities:  

Keywords:  bioresorbable scaffold; coronary artery disease; percutaneous coronary intervention

Mesh：

Substances：

Year:  2019        PMID： 30660461     DOI： 10.1016/j.jcin.2018.11.029

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN： 1936-8798            Impact factor:   11.195


× No keyword cloud information.
  3 in total

1.  Final report of the 5-year clinical outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in the treatment of single de novo coronary lesions in a first-in-human study.

Authors:  Yizhe Wu; Jiasheng Yin; Jiahui Chen; Zhifeng Yao; Juying Qian; Li Shen; Lei Ge; Junbo Ge
Journal:  Ann Transl Med       Date:  2020-09

2.  Three-year clinical outcomes of a sirolimus-eluting bioresorbable scaffold (XINSORB) and a metallic stent to treat coronary artery stenosis.

Authors:  Yizhe Wu; Zhifeng Yao; Jiasheng Yin; Jiahui Chen; Juying Qian; Li Shen; Lei Ge; Junbo Ge
Journal:  Ann Transl Med       Date:  2020-11

Review 3.  Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia.

Authors:  Fengxuan Han; Jiayuan Wang; Luguang Ding; Yuanbin Hu; Wenquan Li; Zhangqin Yuan; Qianping Guo; Caihong Zhu; Li Yu; Huan Wang; Zhongliang Zhao; Luanluan Jia; Jiaying Li; Yingkang Yu; Weidong Zhang; Genglei Chu; Song Chen; Bin Li
Journal:  Front Bioeng Biotechnol       Date:  2020-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.